ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-35008

Products that incorporate the Microhard BulletLTE-NA2 and IPn4Gii-NA2 are vulnerable to a post-authentication command injection issue in the AT+MMNAME command that can lead to priv

Published Jun 8, 2025 · catalog updated Jun 9, 2025 · Microhard IPn4Gii / Bullet-LTE Firmware

Check if you run it

No confirmed exploitation is on record for CVE-2025-35008. EPSS is 1.03%. Act only if a listed version of Microhard IPn4Gii / Bullet-LTE Firmware is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High7.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
1.03%
Remediation
Vendor / distro source
Affected products
vendor Microhard IPn4Gii / Bullet-LTE Firmware 0 ≤v1.2.0-r1132

Products that incorporate the Microhard BulletLTE-NA2 and IPn4Gii-NA2 are vulnerable to a post-authentication command injection issue in the AT+MMNAME command that can lead to privilege escalation. This is an instance of CWE-88, "Improper Neutralization of Argument Delimiters in a Command ('Argument Injection')," and is estimated as a CVSS 7.1 (CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N). This issue has not been generally fixed at the time of this CVE record's first publishing.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Microhard IPn4Gii / Bullet-LTE Firmware 0 ≤v1.2.0-r11320 ≤v1.2.0-r1132

How to fix CVE-2025-35008

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-35008. EPSS is 1.03%. Act only if a listed version of Microhard IPn4Gii / Bullet-LTE Firmware is installed.

Which versions are affected?

Compare what you have installed with Microhard IPn4Gii / Bullet-LTE Firmware 0 ≤v1.2.0-r1132 0 ≤v1.2.0-r1132. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 1.03%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Jun 8, 2025 · EUVD

    Detected

    Products that incorporate the Microhard BulletLTE-NA2 and IPn4Gii-NA2 are vulnerable to a post-authentication command injection issue in the AT+MMNAME command that can lead to privilege escalation. This is an instance of CWE-88, "Improper Neutralization of Argument Delimiters in a Command ('Argument Injection')," and is estimated as a CVSS 7.1 (CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N). This i

  2. Jun 9, 2025 · EUVD

    Updated

    Products that incorporate the Microhard BulletLTE-NA2 and IPn4Gii-NA2 are vulnerable to a post-authentication command injection issue in the AT+MMNAME command that can lead to privilege escalation. This is an instance of CWE-88, "Improper Neutralization of Argument Delimiters in a Command ('Argument Injection')," and is estimated as a CVSS 7.1 (CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N). This i

Sources

  • CVE.orgVulnerability recordCVE-2025-35008

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-35008

    30-day exploitation probability 1.0%

    first.org
  • EUVDVulnerability recordEUVD-2025-17400

    Products that incorporate the Microhard BulletLTE-NA2 and IPn4Gii-NA2 are vulnerable to a post-authentication command injection issue in the AT+MMNAME command that can lead to privilege escalation. This is an instance of CWE-88, "Improper Neutralization of Argument Delimiters in

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.